We intend to target clean energy transition businesses with enterprise values of approximately $250 million to $1 billion. We shall not undertake our initial business combination with any entity with its principal business operations in China (including Hong Kong and Macau). (Note: Monterey Capital Acquisition Corp. downsized its SPAC IPO at pricing on May 10, 2022, by […]

(Note: Navigation Capital Acquisition IX Corp. withdrew its SPAC IPO in an SEC filing dated April 21, 2022; the S-1 filing was dated June 28, 2021.) We intend to target a business and distribution services company.

(Note: Navigation Capital Acquisition VIII Corp. withdrew its SPAC IPO in an SEC filing dated April 21, 2022; the S-1 filing was dated June 28, 2021.) We intend to target a niche manufacturing services company.

(Note: Navigation Capital Acquisition VII Corp., backed by Navigation Capital of Atlanta, withdrew its SPAC IPO in an SEC filing dated April 21, 2021; the S-1 filing was dated June 28, 2021.) We intend to target a telecommunications, media and technology company.

(Note: Navigation Capital Acquisition VI Corp. withdrew its SPAC IPO in an SEC filing dated April 21, 2022; the S-1 was filed June 28, 2021.) We intend to target a specialty finance and financial technology company. Our sponsor has secured financial commitment from an affiliate of Navigation Capital Partners LLC, an Atlanta-based private equity firm […]

We intend to focus our search on businesses in the fast-moving consumer goods, the Internet-based e-commerce technologies and the new energy industries. We will not enter into a business combination with any entity located in China, including Hong Kong and Macau. (Incorporated in the Cayman Islands)  (Fortune Joy International Acquisition Corp. cut the size of its SPAC IPO […]

We intend to pursue prospective targets in the transportation industry with a focus on companies in North America, Europe and Asia. We expect to acquire one or more growth businesses with a total enterprise value of between $200 million and $600 million. (Incorporated in Delaware) Our search for a target business will include those involved […]

We are a clinical biopharmaceutical drug development company focused on novel therapeutics targeting currently untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration (commonly known as dry AMD) and autosomal recessive Stargardt disease, or STGD1, both of which progressively lead to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease […]

We intend to focus our search on businesses that are focused on blockchain-related technology, economy, industries and solutions.  We anticipate targeting companies domiciled in North America, Europe and/or Asia that are developing assets in the FinTech, MedTech, Internet of Things, Media, Education, Enterprise and, Blockchain Enabled Verticals, which aligns with our management team’s experience in […]

(Note: Avanea Energy Acquisition Corp. withdrew its SPAC IPO in an SEC filing dated April 20, 2022; the S-1 was filed on March 23, 2021.)  Our focus will be on the energy technology industry in Europe and North America. (Incorporated in the Cayman Islands)  We will search for a target business with an enterprise value […]